NEW FORMULATIONS OF HYDROCORTISONE-17-BUTYRATE IN THE ARSENAL OF MEANS FOR TOPICAL TREATMENT OF ATOPIC DERMATITIS IN CHILDREN
https://doi.org/10.15690/vsp.v13i4.1088
Abstract
Topical therapy of atopic dermatitis in children is a complex and multifactorial problem. Irrational choice of means of treatment may lead to the deterioration of the child, cause complications of dermatosis, promote the development of «atopic march». Topical treatment’s «Gold standard» is topical corticosteroids. The application of these medicines is not limited to conventional dosage forms such as cream and ointment. The features of the new formulations are presented (emulsions with different lipid concentration), the recommendations on their practical use are stated, the clinical experience of their application in the treatment of children with atopic dermatitis is described.
Keywords
Supporting agencies: “Astellas”
About the Authors
N. G. Korotkii
Pirogov Russian National Research Medical University, Moscow
Russian Federation
Russian Federation
B. N. Gamayunov
Russian Child Clinical Hospital, Moscow
Russian Federation
Korotkii Nikolai Gavrilovich, PhD, professor, Head of Dermatovenereological Department of Pediatric Faculty
Russian Federation
Korotkii Nikolai Gavrilovich, PhD, professor, Head of Dermatovenereological Department of Pediatric Faculty
References
1. Handbook of Atopic Eczema. 2nd edn. Ring J.B. Przybilla, T. Ruzicka (eds.). Heidelberg: Springer. 2006.
2. Ring J. Allergy in Practice. Heidelberg: Springer. 2004. 635 p.
3. Johansson S.G., Bieber T., Dahl R., Friedmann P.S., Lanier B.Q., Lockey R.F. et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. 2004; 113: 832–836.
4. Khaitov R. M., Kubanova A. A. Consilium medicum — Consilium medicum. 2004; 3: 167–173.
5. Carrol C.L., Balkrishnan R., Feldman S.R., Fleisher A.B., Jr, Manuel J.C. The burden of atopic dermatitis: impact on the patient, family and society. Pediatr. Dermatol. 2005; 22: 192–199.
6. Turner J.D., Schwartz R.A. Atopic dermatitis. A clinical challenge. Acta Dermatovenerol. Alp. Panonica Adriat. 2006; 15 (2): 59–68.
7. Ong P.Y., Leung D.Y. Immune dysregulation in atopic dermatitis. Curr. Allergy Asthma Rep. 2006; 6 (5): 384–389.
8. Leung D.Y. Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J. Allergy Clin. Immunol. 2009; 124 (3): 494–495.
9. Korotkii N. G., Tikhomirov A. A., Gamayunov B. N. Klin. dermatol. i venerol. — Clinical dermatology and venereology. 2013; 4: 51–55.
10. Baumer J.H. Guideline review: atopic eczema in children. Arch. Dis. Child. Edu. Pract. Ed. 2008; 93 (3): 93–97.
11. Korotkii N. G., Tikhomirov A. A., Andreenko O. N., Gamayunov B. N. Opyt primeneniya mazi lokoid v terapii detei s khronicheskimi vospalitel’nymi zabolevaniyami kozhi. Sb. trudov yubileinoi nauch.-prakt. konf. «Aktual’nye voprosy i osobennosti dermatovenerologii v detskom vozraste. Problemy i perspektivy» [Experience in the Application of the Ointment Lokoid in Therapy of Children with Chronic Inflammatory Diseases of the Skin. Proceedings of the Anniversary Scientific-Practical. Conf. “Actual Issues and Features of Dermatovenereology in Childhood. Problems and Prospects”]. Moscow, Meditsinskaya kniga, 2007. pp. 91–94.
12. Schafer-Korting M., Kleuser B., Ahmed M., Holtje H.D., Korting H.C. Glucocorticoids for human skin: new aspects of the mechanism of action. Skin Pharmacol. Physiol. 2005; 18: 103–114.
13. Brazzini B., Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am. J. Clin. Dermatol. 2002; 3 (1): 47–58.
14. Tadicherla S., Ross K, Shenefelt P.D., Fenske N.A. Topical corticosteroids in dermatology. J. Drugs Dermatol. 2009; 8 (12): 1093–1105.
15. Pierard GE. Hydrocortisone 17-butyrate (Locoid). A thirtyyear ongoing innovative drug. Rev. Med. Liege. 2006; 61 (2): 128–130.
16. Wieriks J., Hespe W., Jaitly K.D., van Kan B.L. Topical and systemic effects of hydrocortisone 17-butyrate. Dermatologica. 1976; 152 (Suppl. 1): 181–195.
17. Kochergin N. G., Petrunin D. D. Klin. dermatol. i venerol. — Clinical dermatology and venereology. 2011; 6: 84–94.
Review
For citations:
Korotkii N.G., Gamayunov B.N. NEW FORMULATIONS OF HYDROCORTISONE-17-BUTYRATE IN THE ARSENAL OF MEANS FOR TOPICAL TREATMENT OF ATOPIC DERMATITIS IN CHILDREN. Current Pediatrics. 2014;13(4):74-77. (In Russ.) https://doi.org/10.15690/vsp.v13i4.1088
Views:
879
Email this article 
